Herpes Labialis
Information
- Disease name
- Herpes Labialis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02871492 | Completed | Phase 2 | Trial on Efficacy and Safety of Pritelivir Ointment for Treatment of Labial Herpes | November 29, 2016 | October 16, 2017 |
| NCT00297011 | Completed | Phase 2 | Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis | September 2004 | January 2008 |
| NCT00306293 | Completed | Phase 4 | VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 | February 20, 2006 | November 27, 2006 |
| NCT00361881 | Completed | Phase 3 | Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis | July 2006 | December 2007 |
| NCT00375570 | Completed | Phase 3 | Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents | October 2006 | September 2007 |
| NCT00453401 | Completed | Phase 2 | Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes Labialis | February 2007 | December 2007 |
| NCT00469300 | Completed | Phase 2 | Iontophoretic Application of Acyclovir Gel to Treat Cold Sores | April 2007 | October 2007 |
| NCT00711776 | Completed | Phase 1 | Bioequivalence Study of Aciclovir 5% Cream in Japanese Healthy Volunteers | April 10, 2008 | August 17, 2008 |
| NCT00735761 | Completed | Phase 3 | Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised Patients | December 2006 | September 2007 |
| NCT00736437 | Completed | Phase 2 | Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes Labialis | August 1999 | August 2000 |
| NCT00769314 | Completed | Phase 3 | Phase 3 Clinical Study for the Treatment of Cold Sore | May 2007 | August 2009 |
| NCT00878072 | Completed | Phase 2/Phase 3 | Safety and Pharmacokinetics of Famciclovir Single 1500 mg Dose in Adolescents With Recurrent Herpes Labialis | March 25, 2009 | June 2, 2010 |
| NCT03661541 | Completed | Phase 1 | Immune Response and General Immune Health in Subjects Infected With Herpes Simplex Virus Type 1 (HSV-1) | March 2, 2017 | October 25, 2017 |
| NCT01208298 | Completed | N/A | Study to Evaluate Using a Cold Sore Patch to Treat Herpes Labialis | April 2009 | August 2009 |
| NCT03310294 | Completed | N/A | Immune Evidence to the Consumption of Lactobacillus GG and FOS Consumption in Patients With Herpes Labialis | September 14, 2010 | August 1, 2011 |
| NCT01257074 | Completed | Phase 3 | Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes Labialis | February 2012 | October 2012 |
| NCT00230867 | Completed | Phase 2 | Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes Labialis | April 2005 | December 2005 |
| NCT01484067 | Completed | N/A | Study of a Cold Sore Patch for the Treatment of Herpes Labialis | November 2011 | March 2012 |
| NCT01574612 | Completed | Phase 3 | Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old | March 2012 | February 2013 |
| NCT01653509 | Completed | Phase 1 | An Exploratory Study to Investigate the Inflammatory Response During a Cold Sore Episode | July 2012 | September 2012 |
| NCT03307772 | Completed | N/A | Immune Response to the Consumption of Lactobacillus GG and FOS in Patients With Recurrent Herpes Labialis | December 15, 2008 | October 20, 2009 |
| NCT01971385 | Completed | Phase 1 | Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis | October 2013 | September 2015 |
| NCT02207881 | Completed | Phase 2 | A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis | July 2014 | December 2015 |
| NCT02265913 | Completed | Phase 3 | Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis | October 6, 2014 | November 21, 2017 |
| NCT02483182 | Completed | Phase 2 | Safety, Tolerability and Therapeutic Efficacy of Topical ZEP-3 Ointment (1.0%) for the Treatment of Cold Sores | September 2015 | June 24, 2018 |
| NCT02965781 | Completed | Phase 1/Phase 2 | Double-blind, Vehicle-controlled Study of the Efficacy and Safety of SADBE in Subjects With Recurrent Herpes Labialis | December 2016 | December 20, 2018 |
| NCT01306084 | Recruiting | Viral Infections in Healthy and Immunocompromised Hosts | March 15, 2011 | ||
| NCT01225341 | Terminated | N/A | Botulinum Toxin A for Herpes Labialis | August 2010 | June 2012 |
| NCT03521479 | Terminated | Phase 2 | A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis | March 12, 2018 | October 5, 2019 |
| NCT00913692 | Terminated | Phase 2 | A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis | June 2009 | December 2011 |
| NCT04539483 | Terminated | Phase 2 | Monoclonal Antibody Therapy Against Chronic Herpes Simplex Virus 1 Infection | October 8, 2020 | May 31, 2023 |
| NCT02582086 | Unknown status | N/A | Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis | January 2016 | September 2017 |
| NCT01695187 | Unknown status | Phase 3 | NB-001 Treatment of Recurrent Herpes Labialis | October 2012 | July 2013 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D006560